PGR and breast cancer: As a special subtype of breast cancer, triple-negative breast cancer (TNBC) lacks the expression of estrogen receptor (ER), progesterone receptor (PR), and epidermal growth factor receptor 2 (HER2), which severely limits the clinical usage of endocrine and targeted therapy.